Merional 150 is a medication used to treat infertility in women. The active substance in Merional 150 is human menopausal gonadotropin (hMG), which is a naturally occurring hormone given to support the growth and development of ovarian follicles during fertility treatment.

Merional 150 is most often used in women who are undergoing assisted reproductive technologies such as in-vitro fertilization (IVF) or intrauterine insemination (IUI). The medication is typically used in conjunction with other fertility medications such as follicle-stimulating hormone (FSH) to help stimulate ovulation.

Merional 150 is administered through injection, with each ampule containing 150 IU of hMG. It is important that the medication is administered as instructed by a healthcare professional to avoid any potential complications.

The medication is produced by IBSA, a leading pharmaceutical manufacturer. IBSA is known for producing high-quality medications that are effective and safe for use in the treatment of various medical conditions.

Common side effects of Merional 150 may include abdominal pain, bloating, and headache. More serious side effects may include ovarian hyperstimulation syndrome (OHSS), which is a rare but potentially serious complication that can occur as a result of fertility treatment. OHSS can cause symptoms such as abdominal pain, nausea, vomiting, and difficulty breathing. In severe cases, it can lead to kidney failure, fluid accumulation in the lungs, and even death.

In conclusion, Merional 150 is a medication used to treat infertility in women. It contains human menopausal gonadotropin (hMG) as its active ingredient and is available in the form of 1 ampule containing 150 IU of the medication. It is manufactured by IBSA, a reputable pharmaceutical company. Merional 150 should only be administered as directed by a healthcare professional and patients should be monitored closely for potential side effects.


There are no reviews yet.

Be the first to review “Buy MERIONAL 150 Online”

Your email address will not be published. Required fields are marked *